Research in Social and Administrative Pharmacy
Volume 2, Issue 1 , Pages 96-109 , March 2006

A pilot study to describe antidepressant prescriptions dispensed to veterans after stroke

  • L. Douglas Ried, Ph.D.

      Affiliations

    • Rehabilitation Outcomes Research Center (151B), Malcom Randall Veterans Affairs Medical Center, 1601 SW Archer Blvd., Gainesville, FL 32608-1197, USA
    • College of Pharmacy, University of Florida, Gainesville, FL 32610-0496, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 352 376 1611x4969; fax: +1 352 271 4270.
    • ,
  • Michael J. Tueth, M.D.

      Affiliations

    • Department of Psychiatry, Malcom Randall Veterans Affairs Medical Center and Department of Psychiatry, College of Medicine, University of Florida, Gainesville, FL 32608-1197, USA
    • ,
  • Huangang Jia, Ph.D.

      Affiliations

    • Rehabilitation Outcomes Research Center (151B), Malcom Randall Veterans Affairs Medical Center, 1601 SW Archer Blvd., Gainesville, FL 32608-1197, USA

Received 26 August 2005 ,Revised 25 November 2005 ,Accepted 28 November 2005.

References 

  1. American Heart Association. Heart disease and stroke statistics—2004 update. Dallas, Tex, American Heart Association, 2003.
  2. O'Sullivan SB. Stroke. Physical Rehabilitation Assessment and Treatment. 3rd ed.. Philadelphia, Pa: FA Davis and Co.; 1994;
  3. Choi D. Stroke. Neurobiol Dis. 2000;7:552–558
  4. Reker DM, Hamilton BB, Duncan PW, et al. Stroke: who's counting what. J Rehabil Res Dev. 2001;38:281–289
  5. Robinson RG. The Clinical Neuropsychiatry of Stroke. New York: Cambridge University Press; 1998;
  6. Cole MG, Martin G, Elie LM, et al. Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: systematic review. J Geriatr Psychiatry Neurol. 2001;14:37–41
  7. Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial. Stroke. 2000;31:1482–1486
  8. Cherminski E, Robinson RG, Arndt S, et al. The effect of remission of poststroke depression in activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis. 2001;189:421–425
  9. Katon W. Depression: relationship to somatization and chronic medical illness. J Clin Psychiatry. 1984;45:4–11
  10. Gainotti G, Antonucci G, Marra C, et al. Relationship between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry. 2001;71:258–261
  11. González-Torrecillas JL, Mendlewicz J, Lobo A. Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr. 1995;7:547–560
  12. Narushima K, Robinson RG. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window. J Nerv Ment Dis. 2003;191:645–652
  13. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157:351–359
  14. Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829–1838
  15. Narushima K, Kosier JT, Robinson RG. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis. 2002;190:296–303
  16. Kaplan A. Prevention of poststroke depression: is it possible?. Psychiatric Times. 2005;January:10;12
  17. Palomaki H, Kaste M, Berg A, et al. Prevention of poststroke depression: one-year randomised placebo controlled double blind trial of mianserin with 6-month follow-up after therapy. J Neurol Neurosurg Psychiatry. 1999;66:490–494
  18. Rasmussen A, Lunde M, Poulsen DL, Sorenson K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics. 2003;44:216–221
  19. Narushima K, Robinson RG. Stroke-related depression. Curr Atheroscler Rep. 2002;4:296–303
  20. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160:1823–1829
  21. Veterans Affairs Information Resource Center (VIReC). The Medical SAS® Inpatient Datasets—FY2001: a VIReC resource guide. Edward J. Hines, Jr. VA Hospital, Hines, Ill, September 2002.
  22. Statistical Package for the Social Sciences. Release 10.0.5. Chicago, Ill: SPSS Inc.; 1999;
  23. Kotila M, Numminen H, Waltimo O, et al. Depression after stroke: results of the FINNSTROKE Study. Stroke. 1998;29:368–372
  24. Robinson RG, Bolduc PL, Price TR. Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke. 1987;18:837–843
  25. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry. 2004;161:1090–1095
  26. House A, Knapp P, Bamford J, et al. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 2001;32:696–701
  27. Morris PLP, Robinson RG, Andrzejewski P, et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry. 1993;150:124–129
  28. Waknine Y. Off-label use of atypical antipsychotics linked to increased mortality in elderly. Medscape. Available from: <http://www.medscape.com/viewarticle/502902>Accessed 04.20.05
  29. Taylor CB, Youngblood ME, Catellier D, for the ENRICHD Investigators , et al. Effects of antidepressant medications on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62:792–798
  30. American Psychiatric Association . Practice guidelines. Available from: <http://www.psych.org/psych_pract/treatg/quick_ref_guide/Quick%20Reference%20Guides_8904/MajorDepressiveDisorderQRG.pdf>Accessed 03.04.05
  31. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994;
  32. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alpha. N Engl J Med. 2001;344:961–966
  33. Glassman AH, O'Connor CM, Califf RM, for Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group , et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709

PII: S1551-7411(05)00140-3

doi: 10.1016/j.sapharm.2005.11.002

Research in Social and Administrative Pharmacy
Volume 2, Issue 1 , Pages 96-109 , March 2006

Article Tools

* Image Usage & Resolution